In this study, we conducted an integrated analysis of the characteristics of ICD-related genes to evaluate the impact of the expression of these genes on the survival, prognosis, and response to immunotherapy in COAD patients, especially AIM2. The gene discussed is AIM2; the disease is colon adenocarcinoma.